651 Phase 2 trial of AGEN1423, an anti-CD73-TGFβ-Trap bifunctional antibody, in combination with balstilimab, with or without chemotherapy in subjects with advanced pancreatic cancer
Regular and Young Investigator Award Abstracts（2022）
关键词
advanced pancreatic cancer,pancreatic cancer,bifunctional antibody
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要